[HTML][HTML] Organ-on-a-chip meets artificial intelligence in drug evaluation

S Deng, C Li, J Cao, Z Cui, J Du, Z Fu, H Yang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Drug evaluation has always been an important area of research in the pharmaceutical
industry. However, animal welfare protection and other shortcomings of traditional drug …

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery

N Sunildutt, P Parihar… - Frontiers in …, 2023 - frontiersin.org
The inefficiency of existing animal models to precisely predict human pharmacological
effects is the root reason for drug development failure. Microphysiological system/organ-on …

Strategies to reduce the risks of mRNA drug and vaccine toxicity

D Bitounis, E Jacquinet, MA Rogers… - Nature Reviews Drug …, 2024 - nature.com
Abstract mRNA formulated with lipid nanoparticles is a transformative technology that has
enabled the rapid development and administration of billions of coronavirus disease 2019 …

3D human tissue models and microphysiological systems for HIV and related comorbidities

DE Yin, AC Palin, TB Lombo, RN Mahon, B Poon… - Trends in …, 2023 - cell.com
Abstract Three-dimensional (3D) human tissue models/microphysiological systems (eg,
organs-on-chips, organoids, and tissue explants) model HIV and related comorbidities and …

The FDA modernisation act 2.0: Bringing non-animal technologies to the regulatory table

A Stewart, D Denoyer, X Gao, YC Toh - Drug Discovery Today, 2023 - Elsevier
The FDA modernisation Act 2.0 marks a game-changing legislation enabling drug
registration without the absolute requirement for the use of animals in safety toxicology …

[HTML][HTML] Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions

RM Visalakshan, MK Lowrey, MGC Sousa… - Frontiers in …, 2023 - frontiersin.org
Augmenting adaptive immunity is a critical goal for developing next-generation cancer
therapies. T and B cells infiltrating the tumor dramatically influence cancer progression …

Towards in vitro models for reducing or replacing the use of animals in drug testing

DM Stresser, AK Kopec, P Hewitt… - Nature Biomedical …, 2023 - nature.com
Towards in vitro models for reducing or replacing the use of animals in drug testing | Nature
Biomedical Engineering Skip to main content Thank you for visiting nature.com. You are using …

Bioprinting of cardiac tissue in space: Where are we?

K Tabury, E Rehnberg, B Baselet… - Advanced …, 2023 - Wiley Online Library
Bioprinting in space is the next frontier in tissue engineering. In the absence of gravity, novel
opportunities arise, as well as new challenges. The cardiovascular system needs particular …

[HTML][HTML] 3D multicellular systems in disease modelling: from organoids to organ-on-chip

C Goldrick, I Guri, G Herrera-Oropeza… - Frontiers in Cell and …, 2023 - frontiersin.org
Cell-cell interactions underlay organ formation and function during homeostasis. Changes in
communication between cells and their surrounding microenvironment are a feature of …

Human induced pluripotent stem cell–derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family

I Tamargo-Rubio, AB Simpson… - Frontiers in …, 2023 - frontiersin.org
The liver is the primary organ responsible for the detoxification and metabolism of drugs. To
date, a lack of preclinical models that accurately emulate drug metabolism by the human …